Login / Signup

Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper.

Valerie HoxEvelijn LourijsenArnout JordensKristian AasbjergIoana AgacheIsam AlobidClaus BachertKoen BousseryPaloma CampoWytske FokkensPeter HellingsClaire HopkinsLudger KlimekMika MäkeläRalph MösgesJoaquim MullolLaura PujolsCarmen RondonMichael RudenkoSanna Toppila-SalmiGlenis ScaddingSophie ScheirePeter-Valentin TomazicThibaut Van ZeleMartin WagemannJob F M van BovenPhilippe Gevaert
Published in: Clinical and translational allergy (2020)
Because of the inflammatory mechanisms of most chronic upper airway diseases such as rhinitis and chronic rhinosinusitis, systemic steroids have been used for their treatment for decades. However, it has been very well documented that-potentially severe-side-effects can occur with the accumulation of systemic steroid courses over the years. A consensus document summarizing the benefits of systemic steroids for each upper airway disease type, as well as highlighting the potential harms of this treatment is currently lacking. Therefore, a panel of international experts in the field of Rhinology reviewed the available literature with the aim of providing recommendations for the use of systemic steroids in treating upper airway disease.
Keyphrases
  • drug induced
  • oxidative stress
  • clinical practice
  • chronic rhinosinusitis
  • risk assessment
  • combination therapy
  • climate change